Free Trial

Spectral Medical (EDT) Competitors

Spectral Medical logo
C$0.58
-0.01 (-1.69%)
(As of 11/4/2024 ET)

EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and WEED

Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Canopy Growth (WEED). These companies are all part of the "medical" sector.

Spectral Medical vs.

Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, community ranking, analyst recommendations, dividends, earnings and institutional ownership.

Spectral Medical has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500.

Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral MedicalN/A -973.97% -93.22%
Akumin -34.67%-483.86%0.47%

In the previous week, Spectral Medical had 2 more articles in the media than Akumin. MarketBeat recorded 2 mentions for Spectral Medical and 0 mentions for Akumin. Spectral Medical's average media sentiment score of 0.30 beat Akumin's score of 0.00 indicating that Spectral Medical is being referred to more favorably in the media.

Company Overall Sentiment
Spectral Medical Neutral
Akumin Neutral

Spectral Medical received 106 more outperform votes than Akumin when rated by MarketBeat users. Likewise, 65.17% of users gave Spectral Medical an outperform vote while only 64.10% of users gave Akumin an outperform vote.

CompanyUnderperformOutperform
Spectral MedicalOutperform Votes
131
65.17%
Underperform Votes
70
34.83%
AkuminOutperform Votes
25
64.10%
Underperform Votes
14
35.90%

Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral MedicalC$1.90M85.86-C$18.68M-C$0.07-8.29
AkuminC$737.69M0.05-C$255.80M-C$3.80-0.14

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Akumin
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

13.0% of Spectral Medical shares are owned by institutional investors. Comparatively, 30.3% of Akumin shares are owned by institutional investors. 18.2% of Spectral Medical shares are owned by insiders. Comparatively, 33.0% of Akumin shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Spectral Medical beats Akumin on 9 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDT vs. The Competition

MetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE Exchange
Market CapC$163.13MC$27.04MC$5.09BC$4.71B
Dividend Yield1.45%5.44%7.52%6.56%
P/E Ratio-8.292.16135.8825.96
Price / Sales85.861,886.061,688.511,289.64
Price / Cash82.5017.8937.1978.98
Price / Book-7.252.384.613.15
Net Income-C$18.68MC$26.61MC$116.08MC$268.46M
7 Day Performance-3.33%-0.45%-0.97%0.16%
1 Month Performance-3.33%-9.03%5.32%1.53%
1 Year Performance70.59%17.35%33.75%41.34%

Spectral Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDT
Spectral Medical
N/AC$0.58
-1.7%
N/A+70.6%C$163.13MC$1.90M-8.2929News Coverage
AKU
Akumin
N/AC$0.53
+3.9%
N/A+29.3%C$37.20MC$737.69M-0.141,527
GEN
GeneNews
N/AC$0.15
+7.1%
N/AN/AC$25.49MC$234,592.00-2.212,700
LMD
LED Medical Diagnostics
N/AC$0.40
+∞
N/A+0.0%C$15.51MC$14.96M-10.2646Gap Up
LXG
LexaGene
N/AC$0.11
-19.2%
N/A+0.0%C$14.77MC$110,927.00-1.3141High Trading Volume
SQD
SQI Diagnostics
N/AC$0.02
flat
N/A+0.0%C$6.11MC$3.04M-0.30147,000Gap Up
DXD
3D Signatures
N/AC$0.04
+∞
N/A+0.0%C$2.66MN/A-0.91N/AGap Up
MBI
Med Biogene
N/AC$0.05
-18.2%
N/A+0.0%C$597,000.00N/A-7.5080Gap Down
BUX
Biomark Diagnostics
N/AN/AN/AN/A$0.00N/A0.00N/APositive News
Gap Down
High Trading Volume
CRL
Charles River Laboratories International
N/AN/AN/AN/A$0.00N/A0.0021,400Gap Down
WEED
Canopy Growth
0.259 of 5 stars
C$7.68
+13.1%
C$7.12
-7.3%
+790.7%C$651.73MC$287.10M-0.972,700Gap Up

Related Companies and Tools


This page (TSE:EDT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners